ISPE announced the addition of three new keynote presenters for the 2019 ISPE Annual Meeting & Expo. Taking place 27–30 October 2019 in Las Vegas, Nevada, this signature event brings together top pharmaceutical industry and regulatory leaders offering compelling and enlightening presentations and interactive discussions on industry-critical technical developments.
The 2019 ISPE Annual Meeting & Expo features a dynamic line-up of thought-provoking keynote presentations led by some of the most prominent names in the pharmaceutical industry. These senior-level presentations are rounded out by a compelling patient keynote speaker.
Lou Kennedy joined Nephron Pharmaceuticals in 2001 and accepted the position of President and Chief Executive Officer in September 2007. Along with her husband Bill, Kennedy helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy. As CEO of a woman-owned business, Kennedy values female leadership in the workforce.
Alberto Santagostino has a deep knowledge of the manufacturing challenges faced by companies in the biopharma space. Together with his team at Lonza Pharma & Biotech, the leading global CDMO with a prominent presence in new modalities, Alberto’s objective is to serve customers by taking their products through the technical CMC journey to commercialization and industrial scale manufacturing.
Jessica was diagnosed with relapsing MS and after multiple doctors and tests, she discovered ocrelizumab which changed her life by allowing her to treat her body and adjust to her new lifestyle. She has a positive attitude and through sharing of her story encourages others to be their own advocates.
When Drug Research is Personal: A Lifetime Journey to Discover, Create and Manufacture Medicines for Rare Diseases
Every Patient Matters — Transforming to Deliver Breakthroughs Faster
Transforming Big Pharma Manufacturing: Dream or Reality?